The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT)
出版年份 2014 全文链接
标题
The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT)
作者
关键词
-
出版物
IMMUNOLOGICAL REVIEWS
Volume 258, Issue 1, Pages 45-63
出版商
Wiley
发表日期
2014-02-11
DOI
10.1111/imr.12157
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Synergistic Polymorphism at Two Positions Distal to the Ligand-Binding Site Makes KIR2DL2 a Stronger Receptor for HLA-C Than KIR2DL3
- (2014) A. K. Moesta et al. JOURNAL OF IMMUNOLOGY
- NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)
- (2013) R. Romee et al. BLOOD
- Identification of a cellular ligand for the natural cytotoxicity receptor NKp44
- (2013) F. Baychelier et al. BLOOD
- CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia
- (2013) M. L. Green et al. BLOOD
- Influence of KIR gene copy number on natural killer cell education
- (2013) V. Beziat et al. BLOOD
- NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs
- (2013) V. Beziat et al. BLOOD
- CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CML
- (2013) S Ito et al. BONE MARROW TRANSPLANTATION
- Heterodimeric Bispecific Single-Chain Variable-Fragment Antibodies Against EpCAM and CD16 Induce Effective Antibody-Dependent Cellular Cytotoxicity Against Human Carcinoma Cells
- (2013) Daniel A. Vallera et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Matrix metalloproteinases inhibition promotes the polyfunctionality of human natural killer cells in therapeutic antibody-based anti-tumour immunotherapy
- (2013) Q. Zhou et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Targeting Natural Killer Cells to Acute Myeloid Leukemia In Vitro with a CD16 x 33 Bispecific Killer Cell Engager and ADAM17 Inhibition
- (2013) A. Wiernik et al. CLINICAL CANCER RESEARCH
- Identification of a KIR antisense lncRNA expressed by progenitor cells
- (2013) P W Wright et al. GENES AND IMMUNITY
- Membrane-Type 6 Matrix Metalloproteinase Regulates the Activation-Induced Downmodulation of CD16 in Human Primary NK Cells
- (2013) G. Peruzzi et al. JOURNAL OF IMMUNOLOGY
- Allelic Variation in KIR2DL3 Generates a KIR2DL2-like Receptor with Increased Binding to its HLA-C Ligand
- (2013) W. R. Frazier et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: Antibody-Dependent Memory-like NK Cells Distinguished by FcR Deficiency
- (2013) T. Zhang et al. JOURNAL OF IMMUNOLOGY
- Effector Mechanisms of Rejection
- (2013) A. Moreau et al. Cold Spring Harbor Perspectives in Medicine
- A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission
- (2012) N. Vey et al. BLOOD
- A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma
- (2012) D. M. Benson et al. BLOOD
- T and NK cells of B cell NHL patients exert cytotoxicity against lymphoma cells following binding of bispecific tetravalent antibody CD19 × CD3 or CD19 × CD16
- (2012) Lisa M. Pörtner et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- NK cell MHC class I specific receptors (KIR): from biology to clinical intervention
- (2012) Ariane Thielens et al. CURRENT OPINION IN IMMUNOLOGY
- Identification of human NK cells that are deficient for signaling adaptor FcR and specialized for antibody-dependent immune functions
- (2012) I. Hwang et al. INTERNATIONAL IMMUNOLOGY
- Skewing of the NK Cell Repertoire by MHC Class I via Quantitatively Controlled Enrichment and Contraction of Specific Ly49 Subsets
- (2012) P. Brodin et al. JOURNAL OF IMMUNOLOGY
- Virologically Suppressed HIV Patients Show Activation of NK Cells and Persistent Innate Immune Activation
- (2012) G. F. Lichtfuss et al. JOURNAL OF IMMUNOLOGY
- Human Cytomegalovirus (CMV)-Induced Memory-like NKG2C+ NK Cells Are Transplantable and Expand In Vivo in Response to Recipient CMV Antigen
- (2012) B. Foley et al. JOURNAL OF IMMUNOLOGY
- The novel tribody [(CD20)2xCD16] efficiently triggers effector cell-mediated lysis of malignant B cells
- (2012) P Glorius et al. LEUKEMIA
- Bispecific and Trispecific Killer Cell Engagers Directly Activate Human NK Cells through CD16 Signaling and Induce Cytotoxicity and Cytokine Production
- (2012) M. K. Gleason et al. MOLECULAR CANCER THERAPEUTICS
- HLA-C–Dependent Prevention of Leukemia Relapse by Donor ActivatingKIR2DS1
- (2012) Jeffrey M. Venstrom et al. NEW ENGLAND JOURNAL OF MEDICINE
- NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions
- (2011) B. Foley et al. BLOOD
- Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients
- (2011) A. H. Elmaagacli et al. BLOOD
- Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function
- (2011) B. Foley et al. BLOOD
- Heterodimeric bispecific antibody-derivatives against CD19 and CD16 induce effective antibody-dependent cellular cytotoxicity against B-lymphoid tumor cells
- (2011) Christian Kellner et al. CANCER LETTERS
- A single-chain triplebody with specificity for CD19 and CD33 mediates effective lysis of mixed lineage leukemia cells by dual targeting
- (2011) Ingo Schubert et al. mAbs
- Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection
- (2011) S. Lopez-Verges et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Confinement of Activating Receptors at the Plasma Membrane Controls Natural Killer Cell Tolerance
- (2011) S. Guia et al. Science Signaling
- Donor KIR Genes 2DL5A, 2DS1 and 3DS1 Are Associated with a Reduced Rate of Leukemia Relapse After HLA-Identical Sibling Stem Cell Transplantation for Acute Myeloid Leukemia but Not Other Hematologic Malignancies
- (2010) Kate Stringaris et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition
- (2010) K. Schonberg et al. BLOOD
- NK-cell education is shaped by donor HLA genotype after unrelated allogeneic hematopoietic stem cell transplantation
- (2010) P. Haas et al. BLOOD
- NK cells expressing inhibitory KIR for non-self-ligands remain tolerant in HLA-matched sibling stem cell transplantation
- (2010) A. T. Bjorklund et al. BLOOD
- Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood
- (2010) C. G. Brunstein et al. BLOOD
- Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation
- (2010) J. M. Venstrom et al. BLOOD
- Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia
- (2010) S. Cooley et al. BLOOD
- Potentiation of lysis of leukaemia cells by a bispecific antibody to CD33 and CD16 (FcγRIII) expressed by human natural killer (NK) cells
- (2010) Lucia M. R. Silla et al. BRITISH JOURNAL OF HAEMATOLOGY
- Allogeneic natural killer cells for refractory lymphoma
- (2010) Veronika Bachanova et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Progress in metastatic colorectal cancer: growing role of cetuximab to optimize clinical outcome
- (2010) Jesús García-Foncillas et al. Clinical & Translational Oncology
- Anti-GD2 Antibody Therapy for GD2-Expressing Tumors
- (2010) F. Navid et al. CURRENT CANCER DRUG TARGETS
- A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
- (2010) Melissa A. Geller et al. CYTOTHERAPY
- Trastuzumab
- (2010) Karly P. Garnock-Jones et al. DRUGS
- Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment
- (2010) Nathalie T. Joncker et al. JOURNAL OF EXPERIMENTAL MEDICINE
- MHC class I–deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I–sufficient environment
- (2010) Julie M. Elliott et al. JOURNAL OF EXPERIMENTAL MEDICINE
- NK Cell Patrolling and Elimination of Donor-Derived Dendritic Cells Favor Indirect Alloreactivity
- (2010) Kym R. Garrod et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: KIR Antisense Transcripts Are Processed into a 28-Base PIWI-Like RNA in Human NK Cells
- (2010) F. Cichocki et al. JOURNAL OF IMMUNOLOGY
- NK Cells Delay Allograft Rejection in Lymphopenic Hosts by Downregulating the Homeostatic Proliferation of CD8+ T Cells
- (2010) D. Zecher et al. JOURNAL OF IMMUNOLOGY
- NK Cell Regulation of CD4 T Cell-Mediated Graft-versus-Host Disease
- (2010) M. N. Rivas et al. JOURNAL OF IMMUNOLOGY
- Effects of IL-2 on MMP Expression in Freshly Isolated Human NK Cells and the IL-2-independent NK Cell Line YT
- (2010) Karin Edsparr et al. JOURNAL OF IMMUNOTHERAPY
- Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndrome
- (2010) M Carlsten et al. LEUKEMIA
- 'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection
- (2010) Mark T Orr et al. NATURE IMMUNOLOGY
- Critical role for the chemokine receptor CXCR6 in NK cell–mediated antigen-specific memory of haptens and viruses
- (2010) Silke Paust et al. NATURE IMMUNOLOGY
- Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia
- (2009) Q. Zhou et al. BLOOD
- Significant functional heterogeneity among KIR2DL1 alleles and a pivotal role of arginine245
- (2009) R. Bari et al. BLOOD
- Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells
- (2009) F. Romagne et al. BLOOD
- Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity
- (2009) C. G. Brunstein et al. BLOOD
- Education of human natural killer cells by activating killer cell immunoglobulin-like receptors
- (2009) C. Fauriat et al. BLOOD
- Requirements for control of B-cell lymphoma by NK cells
- (2009) Christoph D. Brenner et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Ten years of rituximab in NHL
- (2009) Matthew C Winter et al. Expert Opinion On Drug Safety
- The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
- (2009) Cameron S. Brandt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- NKp44 Receptor Mediates Interaction of the Envelope Glycoproteins from the West Nile and Dengue Viruses with NK Cells
- (2009) O. Hershkovitz et al. JOURNAL OF IMMUNOLOGY
- NK Cell Responsiveness Is Tuned Commensurate with the Number of Inhibitory Receptors for Self-MHC Class I: The Rheostat Model
- (2009) N. T. Joncker et al. JOURNAL OF IMMUNOLOGY
- Matrix Metalloprotease Inhibitors Restore Impaired NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Human Immunodeficiency Virus Type 1 Infection
- (2009) Q. Liu et al. JOURNAL OF VIROLOGY
- KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia
- (2009) R Willemze et al. LEUKEMIA
- Adaptive immune features of natural killer cells
- (2009) Joseph C. Sun et al. NATURE
- Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation
- (2008) L. Vago et al. BLOOD
- The reactivity of Bw4+ HLA-B and HLA-A alleles with KIR3DL1: implications for patient and donor suitability for haploidentical stem cell transplantations
- (2008) B. A. Foley et al. BLOOD
- Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1
- (2008) M. Stern et al. BLOOD
- Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity
- (2008) D. Pende et al. BLOOD
- The transcription factor c-Myc enhances KIR gene transcription through direct binding to an upstream distal promoter element
- (2008) F. Cichocki et al. BLOOD
- The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells
- (2008) P. Brodin et al. BLOOD
- Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia
- (2008) S. Cooley et al. BLOOD
- Natural killer cells recruited into lymph nodes inhibit alloreactive T-cell activation through perforin-mediated killing of donor allogeneic dendritic cells
- (2008) S. Laffont et al. BLOOD
- MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response
- (2008) M. Yawata et al. BLOOD
- Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation
- (2008) Jumei Shi et al. BRITISH JOURNAL OF HAEMATOLOGY
- NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous Malignancy
- (2008) Nadia Guerra et al. IMMUNITY
- KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals
- (2008) B. Foley et al. INTERNATIONAL IMMUNOLOGY
- Accelerated tumor growth in mice deficient in DNAM-1 receptor
- (2008) Akiko Iguchi-Manaka et al. JOURNAL OF EXPERIMENTAL MEDICINE
- DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors
- (2008) Susan Gilfillan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A Novel CD19-directed Recombinant Bispecific Antibody Derivative With Enhanced Immune Effector Functions for Human Leukemic Cells
- (2008) Christian Kellner et al. JOURNAL OF IMMUNOTHERAPY
- Genetic Control of Variegated KIR Gene Expression: Polymorphisms of the Bi-Directional KIR3DL1 Promoter Are Associated with Distinct Frequencies of Gene Expression
- (2008) Hongchuan Li et al. PLoS Genetics
- Regulation of NK cell activity by 2B4, NTB-A and CRACC
- (2007) Maren Claus Frontiers in Bioscience-Landmark
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now